CXCR4 and lung cancer: Using a fixed-effects model, the results showed that increased CXCR4 expression was associated with reduced DFS in lung cancer (HR 3.39, 95% CI 2.38–4.83, P < 0.001, I2 = 0%) (Fig. 2b).